Parameter | Abbreviation (unit) | Duloxetine | Flunitrazepam | Quetiapine | Trazodone |
---|---|---|---|---|---|
Model input parameters | |||||
Molecular weight | MW | 297 | 313 | 384 | 372 |
Octanol–water partition coefficient | logP | 4.26 | 1.78 | 2.99 | 3.85 |
Plasma unbound fraction | fu,p | 0.114 | 0.324 | 0.125 | 0.0732 |
Blood–plasma concentration ratio | Rb | 0.843 | 0.921 | 0.852 | 0.805 |
Liver–plasma concentration ratio | Kp,h | 3.18 | 1.17 | 2.69 | 3.01 |
Fraction absorbed × intestinal availability | Fa·Fg | 1 | 1 | 1 | 1 |
Absorption rate constant | ka (1/h) | 0.372 ± 0.007a | 2.48 ± 0.05 | 2.86 ± 0.05 | 1.12 ± 0.26 |
Transfer rate constant | k12 (1/h) | – | 0.28 ± 0.02 | – | – |
Transfer rate constant | k21 (1/h) | – | 0.04 ± 0.01 | – | – |
Volume of systemic circulation | V1 (L) | 755 ± 1a | 80.7 ± 0.1 | 206 ± 1 | 66.2 ± 9.5 |
Hepatic intrinsic clearance | CLh,int (L/h) | 385 ± 1a | 15.8 ± 0.1 | 954 ± 1 | 173 ± 16 |
Hepatic clearance | CLh (L/h) | 30.2 | 4.84 | 53.4 | 11.2 |
Renal clearance | CLr (L/h) | 3.0 | 0.48 | 5.3 | 1.1 |
Estimated values | |||||
Cmax in plasma | ng/mL | 44.9 (0.93)b | 9.12 (1.08) | 44.2 (0.98) | 491 (0.72) |
AUC in plasma | ng·h/mL | 1210 (1.19) | 52.1 (1.02) | 172 (0.95) | 3610 (0.77) |
Reported levels | |||||
Cmax in plasma | ng/mL | 48.5 ± 8.3c | 8.47d | 45.0e | 681 ± 128f |
AUC in plasma | ng·h/mL | 1020 ± 220 | 51.2 | 181 | 4670 ± 790 |